Experion Announces Leadership ChangeHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Experion Announces Leadership ChangeACCESSWIREJanuary 6, 2020ReblogShareTweetShareVANCOUVER, BC / ACCESSWIRE / January 6, 2020 / Experion Holdings Ltd. (the "Corporation" or "Experion") (EXP.V)(EXPFF)(MB31.F) announces the departure of Chief Executive Officer and director, Jay Garnett, effective January 3, 2020. Experion's board of directors (the "Board") would like to thank Mr. Garnett for his service.The Board has appointed Mr. Jarrett Malnarich as Chief Executive Officer and a director of the Corporation effective immediately. Mr. Malnarich has been the Chief Operating Officer of Experion since October 2017 and served as Interim Chief Executive Officer of Experion from March 2018 to October 15, 2018.Over the course of his career, Mr. Malnarich has been an executive, director and advisor with various public and private companies in the agriculture, biotechnology and cannabis sector. He has secured funding, managed various mergers and acquisitions, and has directly helped numerous cannabis companies in Canada and internationally with licensing, building and executing business plans.About Experion Holdings Ltd.Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of cannabis, based in Mission, BC.Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including adult-use, wellness and therapeutic, and medical products.Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "EXP", on the OTCQB Venture under the symbol "EXPFF" and on the Frankfurt Stock Exchange under the symbol "MB31".For further information, please visit the Company's website www.experionwellness.com or join our Global Investor Forum on 8020 http://connects.company/ExperionEXP where you can read all press releases or contact Investor Relations, Phone: (604) 340-3621, Email: IR@experionwellness.com.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.SOURCE: Experion Holdings Ltd.View source version on accesswire.com: https://www.accesswire.com/572034/Experion-Announces-Leadership-ChangeReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBaidu Becomes Latest Tech Giant to Deliver Disappointing OutlookBloombergToronto Stock Exchange Gets ‘Black Eye,’ Closes Early In RoutBloombergBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoKey Things To Watch Out For If You Are After Evli Pankki Oyj's (HEL:EVLI) 5.8% DividendSimply Wall St.Stock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloomberg'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoDell Technologies (DELL) Matches Q4 Earnings EstimatesZacksDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance